baber/WOPTO huggingface dataset:
Patent PT-2216690-E (PT)
Title: Toner supply container
Inventor: YAMADA YUSUKE
IPC: B41J27/16
Filed: 2002-02-18
Abstract: A toner supply container (1) detachably mountable to an image forming apparatus (100) comprises a container main body (1A) having an inner space adapted to contain toner and an opening (1a) adapted to permit discharge of the toner out of said container (1), a sealing member (2) having a sealing portion (2b) adapted to seal said opening (1a) and a coupling engagement portion (2c) adapted to engage with a cylindrical portion (20) provided in the image forming apparatus (100). The coupling engagement portion (2c) includes a locking portion (3) adapted to be locked with the cylindrical portion (20) to unseal said opening (1a) with relative movement of said sealing portion (2b) and said container main body (1A) away from one another, an elastically deformable supporting portion (2f) adapted to support said locking portion (3) so as to cause said locking portion (3) to displace with relative movement between said locking portion (3) and the cylindrical portion (20) in a direction of overlapping therebetween, and a releasing portion (4) adapted to receive from the image forming apparatus (100) a releasing force for releasing engagement between said locking portion (3) and the cylindrical portion (20) by displacement of said locking portion (3b) with elastic deformation of said supporting portion (2f).
Patent PT-2255685-E (PT)
Title: Vented apparel, vent systems, and associated methods
Inventor: COLLIER JOHN
IPC: A41D1/06
Filed: 2008-02-04
Abstract: One embodiment of the present invention provides a vented apparel, comprising: an outer shell (103); an inner liner (105) disposed adjacent at least a portion of an inside of the outer shell (103); a vent (107) through the outer shell, wherein the vent is substantially covered by a screen (109); a zipper (111) on the inner liner (105); and an adjusting mechanism (113) on the outer shell; wherein the adjusting mechanism (113) is connected to the zipper (111) in order to move the zipper between a closed position and an open position. Another embodiment of the present invention provides a vent system, comprising: a vent (207) through an outer shell (203) of an item incorporating the vent system, wherein the vent is substantially covered by a screen (209); a zipper on an inner liner of the item, wherein the inner liner is disposed adjacent at least a portion of an inside of the outer shell; and an adjusting mechanism (213) on the outer shell (203); wherein the adjusting mechanism is connected to the zipper in order to move the zipper between a closed position and an open position.
Patent PT-745382-E (PT)
Inventor: MIZUMOTO TAKAO
IPC: A61K9/20
Filed: 1995-01-27
Abstract: Intrabuccally dissolving compressed moldings comprising a low moldability saccharide having been granulated with a high moldability saccharide. It shows quick disintegration and dissolution in the buccal cavity and have an adequate hardness.
Patent PT-758651-E (PT)
Inventor: HAMADA YOSHINORI
IPC: A61K9/19
Filed: 1995-04-28
Abstract: The present invention provides a crystal of (1R,5S,6S)-6-Ä(1R)-1-hydroxyethylÜ-2-Ä(3S,5S)-5-sulfamoylaminomethyl-1 -pyrrolidin-3-ylÜthio-1-methyl-1-carba-2-penem-3-carboxylic acid represented by the following formula, a lyophilized preparation comprising the crystal, and a process for producing the same. The production process comprises the steps of freezing an aqueous solution containing the above-mentioned compound by cooling to -20 DEG C or lower; warming the frozen solution to 0 to -10 DEG C; and cooling and warming the frozen solution at least twice in a temperature range of 0 to -10 DEG C. <CHEM>
Patent PT-770102-E (PT)
Inventor: WU WILLIAM W L
IPC: C08G18/75
Filed: 1995-07-14
Abstract: The present invention relates to molded polyurethane/urea elastomers, and specifically to improved polyurethane/urea elastomers having high temperature stability to about 140-150° C. and low temperature flexibility at about -35-(-40)° C., for use in dynamic applications. These elastomers are particularly useful for application in belts, specifically in automotive timing or synchronous belts, V-belts, multi V-ribbed or micro-ribbed belts, flat belting and the like. The polyurethane/urea elastomers of the present invention are prepared by reacting polyisocyanate prepolymers with symmetric primary diamine chain extenders, mixtures of symmetric primary diamine chain extenders and secondary diamine chain extenders, or mixtures of symmetric primary diamine chain extenders and non-oxidative polyols, which are all chosen to eliminate the need for catalysts via standard molding processes, and to improve phase separation. The polyisocyanate prepolymers are reaction products of polyols which are nonoxidative at high temperatures, such as polycarbonate polyols, polyester polyols, or mixtures thereof, with organic polyisocyanates which are either compact, symmetric and aromatic, such as para-phenylene diisocyanate, 1,5-naphthalene diisocyanate, and 2,6-toluene diisocyanate, or are aliphatic and possess trans or trans,trans geometric structure, such as trans-1,4-cyclohexane diisocyanate and trans,trans-4,4'-dicyclohexylmethyl diisocyanate.
Patent PT-880540-E (PT)
Inventor: GATES CYNTHIA A
IPC: A61P43/00
Filed: 1997-01-09
Abstract: The invention related to 4-aza-17 beta -(cyclopropoxy)-androst-5 alpha -androstan-3-one, 4-aza-17 beta -(cyclopropylamino)-androst-4-en-3-one and related compounds and to compositions incorporating these compounds, as well as the inhibition of C17-20 lyase, 5 alpha -reductase and C17 alpha -hydroxylase and to the use of these compounds in the treatment of androgen and estrogen mediated disorders, including benign prostatic hyperplasia, androgen mediated prostate cancer, estrogen mediated breast cancer and to DHT-mediated disorders such as acne. Disorders relating to the oversynthesis of cortisol, for example, Cushing's Syndrome, are also included. The treatment of androgen-dependent disorders also includes a combination therapy with known androgen-receptor antagonists, such as flutamide. The compounds of the invention have general formula (I).
Patent PT-939676-E (PT)
Inventor: ZANDEN JOHANNES PETRUS ANDREAS VAN DER
IPC: B02C13/18
Filed: 1997-10-10
Abstract: The invention relates to a method for directly and multiply making material collide in an essentially deterministic manner, the material being guided by a rotating guide member (8), from a central feed, along a guide face (10) and to a delivery end (11), in such a manner, that the material leaves the guide member, from an essentially predetermined take-off location, at an essentially predetermined take-off angle and at a take-off velocity which can be selected with the aid of the angular velocity, with the instantaneous angle (θ) between the radial line (48) on which the delivery end is situated and the radial line (49) on which is situated the location where the spiral stream (9) and the path of the rotating impact member (14) intersect one another being synchronized in such a way that the impact takes place at an essentially predetermined location, at an essentially predetermined impact angle and at an impact velocity which can be selected with the aid of the angular velocity, whereupon the material, when it comes off the impact face, collides with a collision face of a stationary impact member at a collision velocity which is at least as great as the impact velocity. <IMAGE>
Patent PT-873772-E (PT)
Inventor: WESTON DAVID ROBERT
IPC: H04N7/173
Filed: 1998-04-16
Abstract: An interactive, predictive game control system for use in conjunction with a live TV broadcast received by one or more remote players (C). The system comprises a central controller (1) for generating game playing data for transmission with a TV broadcast to the remote player(s) and for receiving information from the remote player(s). An input device (2) is connected to the central controller (1). A database (4A) is connected to the central controller (1) for storing data relating to the content of the live broadcast and known in advance of the live broadcast. The central controller (1) is responsive to signals from the input device (2):   a) prior to the live broadcast, to select data from the database (4A) for transmission to the remote user(s) in advance of and/or during the live broadcast, and b) during or after the live broadcast, to record the time of occurrence of one or more events relating to the live broadcast which are to be predicted by the remote player(s), as indicated by an operator to the central controller (1) via the input device (2).   <IMAGE>
Patent PT-1048608-E (PT)
Title: Continuous method and apparatus for the sterilization of bottled drinks
Inventor: ZACCHE VANNI
IPC: A23L3/015
Filed: 1999-04-29
Abstract: The present invention relates to a continuous method and associated apparatus for the sterilization of drinks contained in bottles of plastics material, in particular in bottles of polyethylene terephthalate (PET). In particular, the present invention relates to an apparatus for the continuous sterilization of bottled drinks, of the rotary or linear type, comprising a plurality of sterilization devices (10) arranged along the operating line of the apparatus, each of the sterilization devices (10) being fashioned to contain a bottle (6) to be sterilized. The sterilization device (10) is preferably a device for the generation of high hydrostatic pressure. <IMAGE>
Patent PT-1063897-E (PT)
Inventor: PALUCH LAURA
IPC: A23K1/00
Filed: 1999-03-12
Abstract: A dual texture pet food product comprising a cereal based shell component completely surrounding an inner lipid matrix component to form a dual textured pet food product formed by co-extrusion, wherein the shell component is harder than the inner component, said shelf component having a total moisture content of less than 20 wt% and containing at least one ingredient comprising a carbohydrate, fat, protein or combination thereof; and 
said inner component having a water activity, a w  of less than about 0.65, a total moisture content of less than about 15 wt%, and comprising a mixture of lipid and solid ingredients, wherein the inner component does not contain an aqueous phase.
Patent IE-800019-L (IE)
Title: N, n-disubstituted-aminomethyl-phenylethanylamines
IPC: C07D303/36
Filed: 1980-01-07
Abstract: Novel N,N-disubstituted-aminomethylphenylethanolamines of the formula: <CHEM> are claimed, in which: R<1> is hydrogen or alkyl having 1 to 4 carbon atoms R<2> and R<3> are the same or different, each being normal alkyl of from 12 to 20 carbon atoms, and the benzene ring is meta or para disubstituted. Also pharmaceutical formulations useful for treating viral infections in mammals, comprising such compounds and a pharmaceutically acceptable carrier. 
[EP0013592A1]
Patent IE-850022-L (IE)
Title: Acetylerythromcyin stearate
IPC: A61P31/04
Filed: 1985-01-04
Abstract: The invention relates to a new antibiotic compound, acetyl erythromycin stearate having formula I <IMAGE> The compound according to the invention is absorbed readily from the alimentary tract. Gastric acid does not convert the compound according to the invention to an uneffective form as is the case with some other erythromycin antibiotics. Absorbing is good also when the patient eats when taking the new medicine. The compound according to the invention is prepared by reacting erythromycin base with acetyl halide in an organic solvent in the presence of an acid acceptor. The stearate salt is prepared from the obtained ester without in between isolating the ester.
[US4599326A]
Patent IE-900441-L (IE)
Title: Increased protein production in animals
IPC: A23K1/16
Filed: 1990-02-07
Abstract: The present invention provides a method of increasing the ratio of body protein to fat in a animal by maintaining the animal in a hyperimmune state. The invention also provides a method of increasing carcass protein levels in animals. The invention further provides a method for producing lean, low-fat meat for human or animal consumption.
Patent IE-35212-L (IE)
Title: Air drying of tobacco.
IPC: A24B3/04
Filed: 1971-05-10
Abstract: 1281793 Separating particles from gas stream BRITISH-AMERICAN TOBACCO CO Ltd 4 May 1971 [15 June 1970] 12930/71 Heading BIT [Also in Division F4] In a tobacco drier (Division F4) some of the air in which the tobacco is conveyed is bled off from ducts which interconnect a series of drying chambers by valves connected to the inside surfaces of curved portions of the ducts, the tobacco being kept against the outer surfaces of the curved portions by centrifugal forces.
[GB1281793A]
Patent FI-824200-L (FI)
Inventor: ESCHMANN JOACHIM
IPC: H04M3/56
Filed: 1982-12-07
Abstract: A conference circuit in a digital telephone switching system includes a first code converter (CCL), which converts nonlinearly coded speech samples into linearly coded speech samples, and adder (ADD), which sums the converted speech samples originating from the participants in the conference, and a second code converter (LCC), which reconverts the sum values into nonlinearly coded speech samples. To avoid distortion without increasing the insertion loss, the speech samples of the individual participants are integrated with respect to time and compared in an evaluation circuit (EVC). The speech samples of the loudest participant are fed to the adder unattenuated, while those of all other participants are attenuated by a predetermined value before being added.
Patent FI-844398-L (FI)
Inventor: MADI-SZABO LASZLO
IPC: A61K31/715
Filed: 1984-11-08
Abstract: PCT No. PCT/HU84/00016 Sec. 371 Date Nov. 8, 1984 Sec. 102(e) Date Nov. 8, 1984 PCT Filed Mar. 12, 1984 PCT Pub. No. WO84/03442 PCT Pub. Date Sep. 13, 1984.The present invention relates to pharmaceutical compositions comprising 3-dimethylamino-7-methyl-1,2-(n-propylmalonyl)-1,2-dihydro-1,2,4-benzo triazine and at least one of a factor of Vitamine P and/or (+)-2-(3,4-dihydroxyphenyl)-3,5,7-cromanetriole as active ingredients, a process for preparing the same and a method for treating pancreatic inflammations with the said composition. The pharmaceutical compositions according to the invention are useful for the treatment of pancreatic inflammations.
Patent FI-850840-L (FI)
Inventor: STROHMEIER WERNER
IPC: G01N21/47
Filed: 1985-03-01
Abstract: The present invention relates to an apparatus for determining the diffuse reflectivity of a sample surface of small dimensions, especially of the test field of a test strip for determining the substances contained in a body fluid. The apparatus has a semiconductor light emitter, especially a light-emitting diode, for the emission of visible or infrared light to the sample surface, a measuring receiver for receiving the light diffusely reflected by the sample surface and producing an electrical signal corresponding thereto, an evaluating means including an electronic circuit for converting the receiver signal to a value corresponding to the diffuse reflectivity, and a reference channel using the light from the same emitter for the calibration of the apparatus and for the elimination of errors of measurement caused by variations of the emitter or of other electronic components.
Patent IE-39265-L (IE)
Title: Anticoagulants
IPC: C07D311/46
Filed: 1974-05-13
Abstract: 1458670 3-Tetrahydronaphthyl-4-hydroxycoumarin derivatives WARD BLENKINSOP & CO Ltd 23 May 1974 [23 May 1973 25 May 1973 1 March 1974] 24685/73 25264/73 and 9450/74 Heading C2C Novel compounds of the Formula I wherein R<SP>1</SP> and R<SP>2</SP> are the same or different and are hydrogen, halogen, alkyl or alkoxy, R<SP>3</SP> is an (R<SP>4</SP>) m substituted phenyl where m is 1 or 2 and R<SP>4</SP> is the same or different and is halogen, alkyl, alkoxy, cycloalkyl, aralkyl or optionally halogen substituted phenyl or phenoxy, may be prepared by reacting 4-hydroxy coumarin with a compound of the Formula III or IV wherein hal is halogen and optionally separating isomers. 1 - Bromo - 3 - p - diphenyltetralin is prepared by bromination of 3-p-diphenyltetralin-1-ol. 3 - p - Diphenyltetralin - 1 - ol is prepared by reduction of benzyl p-biphenylketone to yield α - benzyl - p . phenylbenzylalcohol followed by chlorination or bromination to yield α-benzyl-pphenylbenzylbromide or chloride which with sodium diethyl malonate followed by hydrolysis yields (1 - p - biphenyl - 2 - phenylethyl)malonic acid which may be decarboxylated to yield 3- p-diphenyl-4-phenyl butyric acid. Both of the above acids cyclize with polyphosphoric acid to yield 3-p-biphenyl tetralin-1-one which is reduced to the required compound. 3 - p - Diphenyl - 4 - phenylbutyric acid is also prepared by reacting benzyl p-biphenyl ketone with ethylbromoacetate and zinc (Reformatsky) to yield ethyl-3-p-biphenyl-3-hydroxy-4-phenyl butyrate which is dehydrated and hydrolysed to 3-benzyl-3-p-biphenyl acrylic acid which is hydrogenated to give the required butyric acid. Compositions of compounds of the Formula I with a carrier may be used as a rodenticide. The compounds are also useful in human medicine.
[GB1458670A]
Patent IE-901062-L (IE)
Title: Liquid transfer devices
IPC: G01N35/10
Filed: 1990-03-22
Abstract: A liquid transfer device of disposable one-time use form to conduct a biochemical diagnostic or other assay comprises two liquid flow channels (10, 110, 210; 20, 120, 220) leading from a respective pair of channel ends to a common site (30, 130, 230) and operable to deliver liquid to this site in sequentially timed manner following simultaneous application of such liquid to the channel ends. Typically respectively different reagents (11, 111, 211; 21, 121, 221) are incorporated in the two channels, and a third reagent (31, 131, 231) at the common site, whereby a sample to be assayed in respect of a particular content can be applied to the site, immobilised by the third reagent, subsequently subjected to one channel reagent to detect any of the content of interest, and finally subjected to the other channel reagent to exhibit for the user any detected content.
[WO9011519A1]
Patent IE-37514-L (IE)
Title: 1,5-benzodiazepines.
IPC: A61P31/04
Filed: 1972-10-13
Abstract: Novel derivatives of 3H-1,5-benzodiazepine and of their salts of addition with acids, including their quaternary ammonium salts, having the general formula: S-X-R2 ¦ N = C ANGLE ANGLE CH2(I) N = C ----- are provided. Such compounds are effective therapeutically against a large spectrum of gram positive bacteria and APR8 influenza virus. The invention also provides a novel method of preparing compounds having the formula: S PARALLEL N--C ANGLE ANGLE CH2 (III) N=C ----- wherein R and R' are the same as above, by reacting orthophenylenediamine with a benzoyldithioacetic acid having the formula: S ----CO-CH2-C ANGLE (II) SH wherein R and R' are as defined above.
[US3933793A]
Patent IE-42898-L (IE)
Title: Telescopic shaft
IPC: F16C29/02
Filed: 1976-07-12
Abstract: A slip joint including telescoped inner and outer members having substantially unstressed plastic material interposed therebetween. The joint is made by first telescoping inner and outer members with the plastic material interposed therebetween. The outer member is then deformed inwardly to place the plastic material under considerable compressive stress. The deformed area is then heated for expanding the plastic material and relieving the compressive stress by plastic movement of the plastic material. The plastic material is then cooled and minimal sliding clearance is provided between the inner member and the plastic material. The outer member is thus deformed inwardly in at least one localized area and the plastic material has a thickness beneath the deformed area which is substantially less than the thickness thereof beyond the deformed area.
[US4033020A]
Patent IE-872062-L (IE)
Title: PYRIDO (2,3-b) (1,4) BENZODIAZEPIN-6-ONES
IPC: C07D471/04
Filed: 1987-07-30
Abstract: Substituted pyrido[2,3-b]-1,4-benzodiazepin-6-ones of the formula I 
<IMAGE>
 in which
 R<1> denotes an alkyl group having 1 to 4 C atoms, a chlorine atom or a hydrogen atom;
 R<2> represents a hydrogen atom or a methyl group;
 R<3> and R<4> each denote a hydrogen atom, a fluorine, chlorine or bromine atom or an alkyl group having 1 to 4 C atoms, but with the proviso that at least one of the radicals R<1>, R<2>, R<3> and R<4> is different from hydrogen,
 R<5> and R<6> represent alkyl radicals having up to 6 carbon atoms and which are identical or different from one another or together with the nitrogen atom between them form a 4- to 7-membered, saturated, monocyclic, heteroaliphatic ring which can optionally be interrupted by an oxygen atom or by the N-CH3 group,
 Z is either a single bond or an oxygen atom, or a methylene or 1,2- ethylene group
 and
 A is a methylene group in position 2 or 3 of the heteroaliphatic ring, or when linked in position 3 is also a single bond, and their salts with inorganic or organic acids are described. 
<??>The compounds of the formula I have favourable effects on the heart rate and are suitable for use in human and veterinary medicine as vagal pacemakers for the treatment of bradycardias and bradyarrhythmias in view of a lack of gastric acid secretion- inhibiting, salivation-inhibiting and mydriatic effects, as well as excellent absorption.
Patent IE-902175-L (IE)
Title: Thioformamide derivatives
IPC: A61P9/10
Filed: 1990-06-15
Abstract: A thioformamide derivative of the formula: <CHEM> wherein R represents alkyl, A represents optionally substituted pyrid-3-yl, isoquinolin-4-yl, tetrahydroquinolin-3-yl, quinolin-3-yl, pyridazin-4-yl, pyrimid-5-yl, thiazol-5-yl, thienoÄ2,3-bÜpyridin-5-yl, pyrazin-2-yl, indol-3-yl, thienoÄ3,2-bÜpyridin-6-yl, or phenyl and Y represents a valency bond, methylene or ethylene, R<2> represents hydrogen, optionally substituted alkyl, cycloalkyl, cycloalkylalkyl, aralkyl, aryloxyalkyl, aromatic heterocyclylalkyl or aromatic heterocyclyloxyalkyl group or a group BC(=O)- or BSO2 - in which B represents optionally substituted alkyl, aryl, or aromatic heterocyclic, n represents 0 or 1, and when n represents 0 R<1> may represent a hydrogen atom, optionally substituted alkyl, cycloalkyl, cycloalkylalkyl, aralkyl, aryloxyalkyl, aromatic heterocyclylalkyl or aromatic heterocyclyloxyalkyl group or a group BC(=O)-, and when n represents 1 R<1> represents optionally substituted alkyl, benzyl, phenethyl, 1-naphthylmethyl, 2-naphthylmethyl or pyrid-3-ylmethyl radical and pharmaceutically acceptable salts thereof possess pharmacological properties.
Patent IE-40442-L (IE)
Title: Polymers with semi-telechelic olefinic unsaturation
IPC: C08F8/00
Filed: 1974-10-24
Abstract: Organic polymer compounds having semi-telechelic olefinic unsaturation, which correspond to the general formula: <IMAGE> in which V is the radical of an organic compound containing at least one polymerizable <IMAGE> group and another group capable of reacting with the functional groups of organic compounds having radicals represented by W and Y; W is the radical of a chain transfer agent RSH, R being an organic radical having at least one hydroxyl or carboxyl group; X is the radical of an organic compound containing a polymerizable <IMAGE> group; Y is the radical of an organic compound containing a polymerizable <IMAGE> group and at least one other reactive group selected from hydroxyl, carboxyl, acid anhydride and epoxy groups; y is 0 or a whole number of from 1 to 10; x is the number of moles of X necessary to enable the chain -(X)x-(Y)y- to have a molecular weight from 1000 to 10,000 and H is the hydrogen atom detached from the chain transfer agent RSH, the radical RS of which is represented by W in the above general formula; the radicals X and the radicals Y being distributed statistically along the polymer chain -(X)x-(Y)y- in accordance with the polymerization kinetics; a process for the preparation thereof, compositions comprising them and coatings or mouldings comprising these compounds or compositions.
[US4177338A]